Tag: Jeffrey Hochberg
AIM Vaccine taps S&C and Jingtian on HKD156m listing on HKEX
China’s biggest privately owned vaccine group AIM Vaccine enlisted legal advice from Sullivan & Cromwell (S&C) and Jingtian & Gongcheng for its debut on the HKEX
LATEST ON VANTAGE ASIA
Knowing is half the battle
Sadaff Habib, an independent arbitrator based in Dubai, points out the major challenges in local arbitration and offers key tips for Chinese businesses
